Non-negligible prevalence of focal lymphocytic sialadenitis in minor salivary glands of non-Sjögren's disease individuals.

IF 3.4 4区 医学 Q2 RHEUMATOLOGY Clinical and experimental rheumatology Pub Date : 2024-12-01 Epub Date: 2024-12-19 DOI:10.55563/clinexprheumatol/ou4fx6
Shubei Liu, Chubing Chen, Qing Zheng, Huimin Sun, Chunjuan Yang, Bin Wang, Guixiu Shi, Donghua Xu, Minning Shen
{"title":"Non-negligible prevalence of focal lymphocytic sialadenitis in minor salivary glands of non-Sjögren's disease individuals.","authors":"Shubei Liu, Chubing Chen, Qing Zheng, Huimin Sun, Chunjuan Yang, Bin Wang, Guixiu Shi, Donghua Xu, Minning Shen","doi":"10.55563/clinexprheumatol/ou4fx6","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Focal lymphocytic sialadenitis (FLS) in minor salivary gland biopsy (MSGB) has long been regarded as a histologic hallmark of Sjögren's disease (SjD), but it can also occur in non-SjD individuals. This study aimed to define the prevalence of FLS in labial minor salivary glands of non-SjD individuals via both an autopsy study and a meta-analysis.</p><p><strong>Methods: </strong>A total of 214 genotype-tissue expression (GTEx) volunteers was included in the autopsy study, and FLS in labial minor salivary gland was evaluated. A meta-analysis was also performed to comprehensively define the prevalence of FLS in labial minor salivary glands of non-SjD individuals.</p><p><strong>Results: </strong>In the autopsy study of 214 GTEx volunteers, the frequency of FLS in labial minor salivary glands was 13.1%. GTEx volunteers aged 60 years and older demonstrated a greater prevalence of FLS compared to those volunteers younger than 60 years (20.3% vs. 9.7%, p=0.03). In the meta-analysis, a total of 8 eligible studies involving 917 labial minor salivary gland samples were included. The pooled prevalence of FLS in labial minor salivary glands of non-SjD individuals was 6.2%. In the subgroup analysis by gender, the pooled prevalence of FLS in labial minor salivary glands for female and male non-SjD individuals was 10.4% and 5.0%, respectively.</p><p><strong>Conclusions: </strong>This study provides compelling epidemiological evidence for the considerably high prevalence of FLS in minor salivary glands of non-SjD individuals. The clinical significance of FLS should be cautiously considered when MSGB is used to confirm seronegative SjD.</p>","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":"42 12","pages":"2499-2506"},"PeriodicalIF":3.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and experimental rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.55563/clinexprheumatol/ou4fx6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Focal lymphocytic sialadenitis (FLS) in minor salivary gland biopsy (MSGB) has long been regarded as a histologic hallmark of Sjögren's disease (SjD), but it can also occur in non-SjD individuals. This study aimed to define the prevalence of FLS in labial minor salivary glands of non-SjD individuals via both an autopsy study and a meta-analysis.

Methods: A total of 214 genotype-tissue expression (GTEx) volunteers was included in the autopsy study, and FLS in labial minor salivary gland was evaluated. A meta-analysis was also performed to comprehensively define the prevalence of FLS in labial minor salivary glands of non-SjD individuals.

Results: In the autopsy study of 214 GTEx volunteers, the frequency of FLS in labial minor salivary glands was 13.1%. GTEx volunteers aged 60 years and older demonstrated a greater prevalence of FLS compared to those volunteers younger than 60 years (20.3% vs. 9.7%, p=0.03). In the meta-analysis, a total of 8 eligible studies involving 917 labial minor salivary gland samples were included. The pooled prevalence of FLS in labial minor salivary glands of non-SjD individuals was 6.2%. In the subgroup analysis by gender, the pooled prevalence of FLS in labial minor salivary glands for female and male non-SjD individuals was 10.4% and 5.0%, respectively.

Conclusions: This study provides compelling epidemiological evidence for the considerably high prevalence of FLS in minor salivary glands of non-SjD individuals. The clinical significance of FLS should be cautiously considered when MSGB is used to confirm seronegative SjD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
不可忽视的流行局灶性淋巴细胞性涎腺炎的小唾液腺non-Sjögren的疾病个体。
目的:小唾液腺活检(MSGB)中的局灶性淋巴细胞性涎腺炎(FLS)一直被认为是Sjögren病(SjD)的组织学标志,但它也可能发生在非SjD个体中。本研究旨在通过尸检研究和荟萃分析来确定非sjd个体的唇小唾液腺中FLS的患病率。方法:选取214名基因型组织表达(GTEx)志愿者进行尸检研究,并对唇小唾液腺的FLS进行评估。还进行了一项荟萃分析,以全面确定非sjd个体的唇小唾液腺中FLS的患病率。结果:在214例GTEx志愿者的尸检研究中,唇部小唾液腺FLS发生率为13.1%。60岁及以上的GTEx志愿者的FLS患病率高于60岁以下的志愿者(20.3%比9.7%,p=0.03)。在荟萃分析中,共纳入8项符合条件的研究,涉及917份唇小唾液腺样本。非sjd个体的唇小唾液腺中FLS的总患病率为6.2%。在性别亚组分析中,女性和男性非sjd个体的唇小唾液腺FLS的总患病率分别为10.4%和5.0%。结论:本研究提供了令人信服的流行病学证据,证明FLS在非sjd个体的小唾液腺中相当高的患病率。在用MSGB确诊SjD血清阴性时,应慎重考虑FLS的临床意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.10
自引率
18.90%
发文量
377
审稿时长
3-6 weeks
期刊介绍: Clinical and Experimental Rheumatology is a bi-monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.
期刊最新文献
Cluster analysis identifies the differential impact of disease activity and severity on functional status and patient satisfaction in rheumatoid arthritis: the FRANK registry. Survival and early outcomes following lung transplantation for interstitial lung disease associated with non-scleroderma connective tissue disease: a national cohort study. A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients. Phase 3, 56-week, randomised, double-blind, placebo-controlled study utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis: OA-11 Study. The association between radiographic progression, functional impairment, markers of dyslipidaemia and inflammation in patients with hand osteoarthritis: a five-year longitudinal study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1